Latest News for VMD
LAFAYETTE, LA / ACCESS Newswire / February 24, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Year End 2025 earnings conference call on Thursday, March 5, 2026, at 11:00 a.m. ET. Interested parties may participate in the call by dialing:…
Viemed Healthcare is reiterated as a 'Buy' due to robust revenue, earnings, and cash flow growth, alongside an expanding patient base. Q1 and Q2 2025 saw strong organic growth, with Lehan's acquisition quickly accretive and driving further patient count gains. Despite recently trimming FY2025 top-line guidance, VMD's valuation remains compelling with P/E, P/S, and P/B well below 5-year averages.
Dallas, Texas--(Newsfile Corp. - January 6, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners initiates their coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VMD.
U.S. House Trading
No House trades found for VMD.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.